
Sign up to save your podcasts
Or


Venrock partner Bryan Roberts chats with Mathai Mammen about COVID-19 vaccine development and therapeutics in this special episode of Running Through Walls. Mammen serves as the Global Head of R&D at the Janssen Pharmaceutical Companies of Johnson & Johnson, where he is heading up the firm's COVID-19 vaccine development. They discuss J&J's unique approach to the vaccine and which therapeutics are promising in the fight against the virus. Mammen shares how the U.S. can be better prepared for the next pandemic, and highlights how his company approaches vaccine production and distribution on a global scale.
By Venrock, a venture capital firm4.8
6262 ratings
Venrock partner Bryan Roberts chats with Mathai Mammen about COVID-19 vaccine development and therapeutics in this special episode of Running Through Walls. Mammen serves as the Global Head of R&D at the Janssen Pharmaceutical Companies of Johnson & Johnson, where he is heading up the firm's COVID-19 vaccine development. They discuss J&J's unique approach to the vaccine and which therapeutics are promising in the fight against the virus. Mammen shares how the U.S. can be better prepared for the next pandemic, and highlights how his company approaches vaccine production and distribution on a global scale.

1,299 Listeners

2,674 Listeners

2,453 Listeners

1,095 Listeners

342 Listeners

338 Listeners

391 Listeners

5,657 Listeners

10,219 Listeners

35 Listeners

562 Listeners

21 Listeners

297 Listeners

459 Listeners

1,476 Listeners